Yorba Linda, CA, United States of America

Elaine Benaksas Schwartz


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elaine Benaksas Schwartz: Innovator in Non-Steroidal Anti-Inflammatory Drug Development

Introduction

Elaine Benaksas Schwartz is a notable inventor based in Yorba Linda, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal anti-inflammatory drugs (NSAIDs). Her innovative work has the potential to improve treatment options for various diseases and illnesses in mammals.

Latest Patents

Elaine holds a patent for "R-NSAID esters and their use." This invention concerns esters of R-enantiomers of a non-steroidal anti-inflammatory drug that is substantially free from the S-enantiomer. The compounds developed in this patent may be utilized in treating diseases or illnesses in mammals. The invention emphasizes the administration of a composition comprising the aforementioned compounds, or a pharmaceutically acceptable salt thereof, in amounts sufficient to elicit chemopreventative, chemoprotective, therapeutic, or prophylactic effects.

Career Highlights

Elaine has dedicated her career to advancing pharmaceutical innovations. Her work at Encore Pharmaceuticals, Inc. has been instrumental in the development of new therapeutic options. With her expertise, she has contributed to the enhancement of drug formulations that aim to provide better health outcomes for patients.

Collaborations

Elaine collaborates with various professionals in her field, including her coworker William J. Wechter. Their combined efforts contribute to the ongoing research and development of effective pharmaceutical solutions.

Conclusion

Elaine Benaksas Schwartz is a pioneering inventor whose work in the field of non-steroidal anti-inflammatory drugs has the potential to significantly impact medical treatments. Her innovative contributions continue to shape the future of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…